Tourmaline Bio
TRML
TRML
53 hedge funds and large institutions have $27.5M invested in Tourmaline Bio in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
61% less capital invested
Capital invested by funds: $71M → $27.5M (-$43.5M)
Holders
53
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$877K | |
| 2 | +$156K | |
| 3 | +$81K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$71.8K |
| 5 |
Two Sigma Investments
New York
|
+$70.9K |
Top Sellers
| 1 | -$906K | |
| 2 | -$521K | |
| 3 | -$460K | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$212K |
| 5 |
Millennium Management
New York
|
-$140K |